First Capital
FCAP
8 hedge funds and large institutions have $876K invested in First Capital in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
14% more funds holding
Funds holding: 7 → 8 (+1)
2% more capital invested
Capital invested by funds: $863K → $876K (+$13K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$29.5K |
| 2 |
WA
Winfield Associates
Cleveland,
Ohio
|
+$11.7K |
| 3 |
Citigroup
New York
|
+$1.01K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$26 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2.65K |
| 3 |
Morgan Stanley
New York
|
-$159 |
FCAP Hedge Fund Activity: Q3 2015 in Review
8 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in First Capital (FCAP) for Q3 2015, worth a combined $876K — up 1.5% from $863K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FCAP positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $29.5K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $4K sold.
- 8 institutional investors held First Capital (FCAP) as of Q3 2015, up from 7 in Q2 2015.
- Funds reported $876K of First Capital stock for Q3 2015, up 1.5% quarter-over-quarter.
- 2 funds opened new First Capital positions in Q3 2015 and 1 closed out, a net change of +1 holder.
- The largest First Capital buyer in Q3 2015 was UBS Group, an estimated $29.5K added.
- The largest First Capital seller in Q3 2015 was Tower Research Capital (TRC), an estimated $4K sold.
Based on aggregated 13F filings for Q3 2015.